Charlotte Hubbert Email Address

Senior Director, Business Development and Strategic Alliances

We seek to unlock the possibility inside every individual. We see equal value in all lives. And so we are dedicated to improving the quality of life for individuals around the world. From the education of students in Chicago, to the health of a young mother in Nigeria, we are catalysts of human promise everywhere.

Dr. Charlotte Hubbert is Senior Director, Business Development & Strategic Alliances at NanoString. Charlotte has over fifteen years basic science research background and over ten years biotech venture investment experience across a broad range of sectors, therapeutic modalities, and stages. Charlotte has a proven ability to combine deep scientific expertise and business development acumen to identify innovative opportunities to drive both returns and impact. She recently joined Madrona Venture Group as a Strategic Director to advise their growing life sciences portfolio. Charlotte was previously Partner and head of Gates Foundation Venture Capital, a $500mm initiative at the Bill and Melinda Gates Foundation Strategic Investment Fund where she oversaw investing in innovative technologies that supported the foundation’s programs in global health and agriculture. Notably she led investments and served on the board of directors of Synlogic (Nasdaq: SYBX), Sera Prognostics, Lodo Therapeutics, Agtech Accelerator, Vedanta, and Vir Biotechnology (Nasdaq: VIR). Charlotte currently serves on the BODs of Entrinsic Health and Nuvara Therapeutics. Charlotte currently serves of the BOD of the Beckman Research Institute at the City of Hope. Prior to joining the foundation, Charlotte was a vice president at H.I.G. BioVentures, investing broadly in healthcare. Charlotte began her career in early stage biotech, investing at Accelerator Corporation, where she was part of the founding team and oversaw management of five companies: Oncofactor, Groove Biopharma, Acylin Therapeutics, Xori, and Pharmselex. Charlotte earned a B.S. in microbiology from the University of Washington and a Ph.D. in pharmacology and cancer biology from Duke University for which she received the prestigious Harold Weintraub Award. She did her post-doctoral work in stem cells and regenerative medicine at the Institute for Stem Cells and Regenerative Medicine at the UW. Charlotte is a member of the Kauffman Society of Fellows (Class 14) and serves on the BOD of Life Science Washington, and the steering committees of the Fred Hutch Cancer Institute’s Evergreen Fund, UW Innovation Roundtable and Columbia University Lab-to-Market initiative. Charlotte has been honored as a Fierce Woman in Biopharma 2016 by FiercePharma, and as a leading Woman in Life Sciences 2016 by Life Science Washington.